Exane Derivatives’s CNH Industrial CNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-34
Closed -$14.3K 734
2019
Q1
$14.3K Buy
34
+16
+89% +$143 ﹤0.01% 377
2018
Q4
$7.05K Sell
18
-211
-92% -$1.86K ﹤0.01% 481
2018
Q3
$82.7K Buy
229
+12
+6% +$119 0.02% 339
2018
Q2
$175K Sell
217
-139
-39% -$1.44K 0.03% 276
2018
Q1
$54.5K Buy
356
+343
+2,638% +$4.15K 0.01% 346
2017
Q4
$5.08K Sell
13
-147
-92% -$1.63K ﹤0.01% 426
2017
Q3
$29.3K Sell
160
-79
-33% -$796 0.01% 341
2017
Q2
$91.6K Sell
239
-281
-54% -$2.65K 0.02% 280
2017
Q1
$68.8K Buy
520
+417
+405% +$3.4K 0.02% 252
2016
Q4
$11.5K Sell
103
-77
-43% -$539 ﹤0.01% 391
2016
Q3
$35.8K Buy
+180
New +$1.12K 0.01% 327
2016
Q2
Sell
-179
Closed -$122K 635
2016
Q1
$122K Buy
179
+69
+63% +$389 0.02% 222
2015
Q4
$46.1K Sell
110
-91
-45% -$550 0.01% 264
2015
Q3
$161K Buy
+201
New +$1.46K 0.02% 199
2015
Q1
Sell
-399
Closed -$157K 564
2014
Q4
$157K Buy
+399
New +$2.77K 0.02% 243

Other funds holding CNH

Exane Derivatives's CNH Position: Q2 2022 in Review

Exane Derivatives reduced its CNH Industrial (CNH) stake by 100% in Q2 2022, selling an estimated $428K and leaving 121 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Exane Derivatives first reported a position in CNH in Q4 2014 and has held it in 19 quarters since. The position peaked at $11.4M in Q4 2021. 271 funds tracked by Wall St. Rank hold CNH as of Q2 2022.

  • Exane Derivatives held 121 shares of CNH Industrial worth $1.66K as of Q2 2022.
  • Exane Derivatives sold 30,014 CNH Industrial shares in Q2 2022, an estimated $428K.
  • CNH Industrial made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #461 holding.
  • Exane Derivatives first reported a position in CNH Industrial in Q4 2014 and has held it in 19 quarters since.
  • Exane Derivatives's CNH Industrial position peaked at $11.4M in Q4 2021.
  • 271 funds tracked by Wall St. Rank held CNH Industrial as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.